The Journal of Experimental Medicine,
Год журнала:
2022,
Номер
219(8)
Опубликована: Июнь 16, 2022
Recessive
or
dominant
inborn
errors
of
type
I
interferon
(IFN)
immunity
can
underlie
critical
COVID-19
pneumonia
in
unvaccinated
adults.
The
risk
children,
which
is
much
lower
than
adults,
remains
unexplained.
In
an
international
cohort
112
children
(<16
yr
old)
hospitalized
for
pneumonia,
we
report
12
(10.7%)
aged
1.5–13
with
(7
children),
severe
(3),
and
moderate
(2)
4
the
15
known
clinically
recessive
biochemically
complete
IFN
immunity:
X-linked
TLR7
deficiency
children)
autosomal
IFNAR1
(1),
STAT2
TYK2
(3)
deficiencies.
Fibroblasts
deficient
IFNAR1,
STAT2,
are
highly
vulnerable
to
SARS-CoV-2.
These
deficiencies
were
not
found
1,224
adults
benign
SARS-CoV-2
infection
without
(P
=
1.2
×
10−11)
overlapping
age,
sex,
consanguinity,
ethnicity
characteristics.
may
∼10%
hospitalizations
children.
Science Immunology,
Год журнала:
2022,
Номер
7(67)
Опубликована: Янв. 7, 2022
Coronavirus
disease
2019
(COVID-19)
is
a
characterized
by
profound
dysregulation
of
the
innate
immune
system.
This
knowledge
has
emerged
from
large
body
single-cell
omics
studies
patients
with
COVID-19,
which
have
provided
one
most
detailed
cellular
atlases
human
ever.
However,
we
are
only
beginning
to
understand
immunological
pathways
that
govern
host
defense
and
immunopathology
in
COVID-19.
In
this
review,
discuss
emerging
understanding
how
SARS-CoV-2
host-derived
molecules
activate
specific
pattern
recognition
receptors
elicit
protective
interferon
responses
pathological
cytokine
responses,
particular
focus
on
acute
infection
lung
pathophysiology
critical
addition,
these
modulated
virus-host
interactions
stress-sensing
pathways.
In-depth
mechanisms
will
likely
uncover
molecular
targets
for
treatment
COVID-19
other
viral
infections.
it
reveal
fine
balance
between
beneficial
versus
causing
responses.
Proceedings of the National Academy of Sciences,
Год журнала:
2022,
Номер
119(21)
Опубликована: Май 16, 2022
Significance
There
is
growing
evidence
that
preexisting
autoantibodies
neutralizing
type
I
interferons
(IFNs)
are
strong
determinants
of
life-threatening
COVID-19
pneumonia.
It
important
to
estimate
their
quantitative
impact
on
mortality
upon
SARS-CoV-2
infection,
by
age
and
sex,
as
both
the
prevalence
these
risk
death
increase
with
higher
in
men.
Using
an
unvaccinated
sample
1,261
deceased
patients
34,159
individuals
from
general
population,
we
found
against
IFNs
strongly
increased
infection
fatality
rate
at
all
ages,
men
women.
Autoantibodies
common
predictors
COVID-19.
Testing
for
should
be
considered
population.
Journal of Translational Medicine,
Год журнала:
2022,
Номер
20(1)
Опубликована: Март 16, 2022
Abstract
Autoimmunity
has
emerged
as
a
characteristic
of
the
post-COVID
syndrome
(PCS),
which
may
be
related
to
sex.
In
order
further
investigate
relationship
between
SARS-CoV-2
and
autoimmunity
in
PCS,
clinical
serological
assessment
on
100
patients
was
done.
Serum
antibody
profiles
against
self-antigens
infectious
agents
were
evaluated
by
an
antigen
array
chip
for
116
IgG
104
IgM
antibodies.
Thirty
pre-pandemic
healthy
individuals
included
control
group.
The
median
age
49
years
(IQR:
37.8
55.3).
There
47
males.
time
219
143
258)
days.
Latent
polyautoimmunity
found
83%
62%
patients,
respectively.
Three
developed
overt
autoimmune
disease.
antibodies
IL-2,
CD8B,
thyroglobulin
more
than
10%
patients.
Other
autoantibodies,
such
anti-interferons,
positive
5–10%
Anti-SARS-CoV-2
>
85%
positively
correlated
with
age,
body
mass
index
(BMI).
Few
autoantibodies
influenced
BMI.
no
effect
gender
over-
or
under-expression
autoantibodies.
anti-IFN-λ
associated
persistence
respiratory
symptoms.
summary,
is
latent
correlates
humoral
response
SARS-CoV-2.
Science,
Год журнала:
2021,
Номер
374(6571), С. 1080 - 1086
Опубликована: Ноя. 25, 2021
Disease
and
accompanying
inflammation
are
uncommon
outcomes
of
viral
infection
in
humans.
Clinical
occurs
if
steady-state
cell-intrinsic
leukocytic
immunity
to
viruses
fails.
Inflammation
attests
the
attempts
newly
recruited
activated
leukocytes
resolve
blood
or
tissues.
In
confusing
battle
between
a
myriad
cells,
studies
human
genetics
can
separate
root
cause
disease
from
its
consequences.
Single-gene
inborn
errors
underlying
diverse
infections
skin,
brain,
lungs
help
clarify
determinants
disease.
The
genetic
elucidation
immunological
deficits
single
patient
with
specific
vulnerability
profile
reveal
mechanisms
that
may
be
triggered
by
other
causes,
inherited
otherwise,
patients.
This
dissection
is
giving
rise
new
biology
medicine.
Multisystem
inflammatory
syndrome
in
children
(MIS-C)
is
a
rare
and
severe
condition
that
follows
benign
COVID-19.
We
report
autosomal
recessive
deficiencies
of
OAS1
,
OAS2
or
RNASEL
five
unrelated
with
MIS-C.
The
cytosolic
double-stranded
RNA
(dsRNA)–sensing
generate
2′-5′-linked
oligoadenylates
(2-5A)
activate
the
single-stranded
RNA–degrading
ribonuclease
L
(RNase
L).
Monocytic
cell
lines
primary
myeloid
cells
OAS1,
OAS2,
RNase
produce
excessive
amounts
cytokines
upon
dsRNA
acute
respiratory
coronavirus
2
(SARS-CoV-2)
stimulation.
Exogenous
2-5A
suppresses
cytokine
production
OAS1-deficient
but
not
L–deficient
cells.
Cytokine
impaired
by
MDA5
RIG-I
deficiency
abolished
mitochondrial
antiviral-signaling
protein
(MAVS)
deficiency.
Recessive
OAS–RNase
these
patients
unleash
SARS-CoV-2–triggered,
MAVS-mediated
mononuclear
phagocytes,
thereby
underlying
Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Март 9, 2022
Abstract
COVID-19
shares
the
feature
of
autoantibody
production
with
systemic
autoimmune
diseases.
In
order
to
understand
role
these
immune
globulins
in
pathogenesis
disease,
it
is
important
explore
spectra.
Here
we
show,
by
a
cross-sectional
study
246
individuals,
that
autoantibodies
targeting
G
protein-coupled
receptors
(GPCR)
and
RAS-related
molecules
associate
clinical
severity
COVID-19.
Patients
moderate
severe
disease
are
characterized
higher
levels
than
healthy
controls
those
mild
disease.
Among
anti-GPCR
autoantibodies,
machine
learning
classification
identifies
chemokine
receptor
CXCR3
molecule
AGTR1
as
targets
for
antibodies
strongest
association
severity.
Besides
antibody
levels,
network
signatures
also
changing
patients
intermediate
or
high
Although
our
current
previous
studies
identify
natural
components
human
biology,
their
deregulated
level
pattern
alterations
might
predict
Journal of Clinical Investigation,
Год журнала:
2021,
Номер
131(24)
Опубликована: Окт. 28, 2021
Acute
COVID-19,
caused
by
SARS-CoV-2,
is
characterized
diverse
clinical
presentations,
ranging
from
asymptomatic
infection
to
fatal
respiratory
failure,
and
often
associated
with
varied
longer-term
sequelae.
Over
the
past
18
months,
it
has
become
apparent
that
inappropriate
immune
responses
contribute
pathogenesis
of
severe
COVID-19.
Researchers
working
at
intersection
COVID-19
autoimmunity
recently
gathered
an
American
Autoimmune
Related
Diseases
Association
Noel
R.
Rose
Colloquium
address
current
state
knowledge
regarding
two
important
questions:
Does
established
predispose
COVID-19?
And,
same
time,
can
SARS-CoV-2
trigger
de
novo
autoimmunity?
Indeed,
work
date
demonstrated
10%
15%
patients
critical
pneumonia
exhibit
autoantibodies
against
type
I
interferons,
suggesting
preexisting
underlies
disease
in
some
patients.
Other
studies
have
identified
functional
following
such
as
those
promote
thrombosis
or
antagonize
cytokine
signaling.
These
may
arise
a
predominantly
extrafollicular
B
cell
response
more
prone
generating
autoantibody-secreting
cells.
This
Review
highlights
understanding,
evolving
concepts,
unanswered
questions
provided
this
unique
opportunity
determine
mechanisms
which
viral
be
exacerbated
by,
even
trigger,
autoimmunity.
The
potential
role
post-acute
sequelae
also
discussed.